Maine Patent of the Month – January 2024

RxAnte, Inc. is developing technologies to advance pharmacy care management by integrating novel analytics and value-based pharmacy services. 

The company has pioneered a revolutionary system that brings precision and efficiency to patient care. This groundbreaking invention focuses on identifying a patient population in a healthcare program through a sophisticated predictive function applied to patient characteristics.

The innovative method begins with the determination of a list of healthcare providers and patients, setting the stage for a targeted approach. RxAnte’s system goes beyond traditional methods by generating adherence risk scores for each patient using a predictive function. This score becomes a critical tool in tailoring interventions and maximizing the impact of healthcare programs. By applying this score to the list of patients, a subset is identified based on factors related to the likelihood of adherence post-intervention.

The user interface, a key aspect of this inventive system, takes center stage with its dynamic capabilities. The first view provides a comprehensive overview, identifying prescribers and patients, along with an itemized listing of therapy areas for each patient in the subset. Notably, monetary indications associated with therapies add a layer of financial insight, enhancing decision-making.

The system seamlessly integrates historical data for each patient, applying it to generate a prediction function. This predictive analytics model undergoes a meticulous setup procedure, including the division of data into training and validation files, ensuring its accuracy and reliability.

This method isn’t just about predicting outcomes; it’s about leveraging data to optimize healthcare delivery, improve medication adherence, and drive tangible benefits for both healthcare providers and patients. RxAnte’s invention represents a paradigm shift, harnessing the power of predictive analytics to reshape the future of patient care.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts